Medication info

NutriFlex Lipid Plus Injection

Prescription medicationIntravenous injection
Ingredient · strength
Glucose Monohydrate›132gMonobasic Sodium Phosphate Dihydrate›1872mgZinc Acetate Hydrate›5.264mgSoybean Oil›20gTriglycerides Medium-Chain›20gIsoleucine›2.256gL-Leucine›3.008gLysine Hydrochloride›2.728gMethionine›1.88gPhenylalanine›3.368gThreonine›1.744gTryptophan›0.544gValine›2.496gArginine›2.592gL-Histidine Hydrochloride Monohydrate›1.624gAlanine›4.656gAspartic Acid›1.44gGlutamic Acid›3.368gGlycine›1.584gProline›3.264gSerine›2.88gSodium Hydroxide›0.781gSodium Chloride›0.402gSodium Acetate Hydrate›0.222gPotassium Acetate›2.747gMagnesium Acetate Tetrahydrate›0.686gCalcium Chloride Hydrate›0.47g
Manufacturer / importer
B.Braun Korea Co., Ltd
Appearance
An emulsion for infusion, colorless and transparent, contained in a bag made of polyamide and polypropylene divided into three compartments: two on the top and one on the bottom.
Packaging
bag - 1875 milliliters/bag
Approval status
Active

MFDS item code 200511366 · Approved 2005.11.04 · Insurance code 667400600

Summary

Main use
Correction of malnutrition through intravenous administration of nutrients (fluids, electrolytes, amino acids, etc.)
Who receives it
Adults
Adult administration
Administer by central venous infusion. Determine the infusion rate based on the total dose, the characteristics of the final admixture to be infused, the daily dose, and the infusion time. In general, gradually increase the dose over the first 30 minutes of infusion until the appropriate dose is reached. There is no set limit on the duration of administration; however, appropriate minerals and vitamins should be provided during long-term administration. Do not exceed a maximum infusion rate of 2.0mL/kg/hour. (Equivalent to amino acids 0.08 g/kg/hour, glucose 0.24 g/kg/hour, and fat 0.08g/kg/hour) Determine the dose according to the patient's condition, energy expenditure, and metabolic requirements. - Determine the dose according to the patient's nutritional status and degree of catabolism, but do not exceed 40kcal/kg per day. Exceptions may be made in special cases, such as patients with burns. - Maximum daily dose: 40mL per kg of the patient's body weight (equivalent to amino acids 1.54g, glucose 4.8g, and fat 1.6g per kg of body weight)

Ingredients

Importer
B.Braun Korea Co., Ltd

Efficacy & effects

Correction of malnutrition through intravenous administration of nutrients (fluids, electrolytes, amino acids, etc.)

View approved original text

This medication provides necessary fluids, electrolytes, amino acids, and calories intravenously to maintain and restore nutritional status for patients who are unable to intake nutrition orally or through the gastrointestinal tract. It is used for nutritional supplementation therapy when eating is impossible or insufficient.

How it is given

Adult administration

Administer by central venous infusion. Determine the infusion rate based on the total dose, the characteristics of the final admixture to be infused, the daily dose, and the infusion time. In general, gradually increase the dose over the first 30 minutes of infusion until the appropriate dose is reached. There is no set limit on the duration of administration; however, appropriate minerals and vitamins should be provided during long-term administration. Do not exceed a maximum infusion rate of 2.0mL/kg/hour. (Equivalent to amino acids 0.08 g/kg/hour, glucose 0.24 g/kg/hour, and fat 0.08g/kg/hour) Determine the dose according to the patient's condition, energy expenditure, and metabolic requirements. - Determine the dose according to the patient's nutritional status and degree of catabolism, but do not exceed 40kcal/kg per day. Exceptions may be made in special cases, such as patients with burns. - Maximum daily dose: 40mL per kg of the patient's body weight (equivalent to amino acids 1.54g, glucose 4.8g, and fat 1.6g per kg of body weight)

Precautions

This medication should be used strictly according to a doctor's instructions, and administration must be immediately discontinued if any allergic reactions such as fever, tremors, rash, or difficulty breathing occur. When used with intravenous calcium preparations, avoid mixing or administering simultaneously. If the same infusion line is to be used, thorough washing is required. Particularly in premature or low birth weight infants, lipid metabolism can be challenging and pose risks, so caution is necessary. Do not administer to specific patient populations such as premature infants, neonates, those with allergies to eggs or soybean oil, and patients with severe renal or liver disease. In patients with renal failure, liver dysfunction, heart failure, diabetes, and other specific conditions, administration should be cautious, and blood lipid and electrolyte levels should be monitored frequently. Overdosage or rapid infusion can cause side effects; if symptoms such as fever, shaking, vomiting, or difficulty breathing appear, discontinue administration immediately. Long-term use may result in liver dysfunction or blood abnormalities, so regular testing is required. Before administration, fluid, electrolyte, and acid-base balance should be improved, and blood glucose and lipid levels should be monitored periodically. This medication may interact with other drugs; thus, consult with a specialist if other medications are being taken. During pregnancy or breastfeeding, the safety of this medication has not been established, so it should be administered with caution. When conducting blood tests, the lipid components in this medication may affect the test results, so it is advisable to have blood drawn 5 to 6 hours after administration. Severe symptoms such as acidosis, fluid overload, hyperglycemia, and dehydration may occur with overdose, so adhere strictly to dosage and administration rate. Do not use if the packaging is damaged or if the solution has deteriorated. Administer immediately after opening, and do not reuse any remaining solution. Ensure to maintain aseptic conditions during preparation for administration, and store in a sealed container protected from light at a cool temperature of 15 to 25°C; avoid freezing.

Side effects

  • Increased body temperature
  • sweating
  • tremors
  • headache
  • vomiting
  • respiratory distress
  • elevated liver function test results
  • hepatomegaly
  • jaundice
  • thrombophlebitis
Show 27 more
  • hyperlipidemia
  • fever
  • fatty infiltration
  • splenomegaly
  • anemia
  • leukopenia
  • thrombocytopenia
  • coagulation abnormalities
  • coma
  • flushing
  • chills
  • loss of appetite
  • nausea
  • respiratory impairment
  • pain in the thoracic and lumbar region
  • hypertension
  • hypotension
  • hypersensitivity reactions
  • skin erythema
  • cyanosis
  • tissue fat accumulation
  • pathological liver dysfunction
  • abnormal blood symptoms
  • abdominal pain
  • fatigue
  • phlebitis
  • thrombophlebitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to avoid exposure to air and light, preferably in a cool temperature range of 15 to 25 degrees Celsius.

Appearance and packaging

Appearance

An emulsion for infusion, colorless and transparent, contained in a bag made of polyamide and polypropylene divided into three compartments: two on the top and one on the bottom.

Package unit

bag - 1875 milliliters/bag

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.